Previous studies revealed up-regulated Kcr level in cancers, including colon, prostate, thyroid, esophagus, pancreas, and lung neoplasms, and down-regulated Kcr level in cancers, including liver, stomach, and kidney carcinomas [13, 25]. This evidence concerns the gene CLEC4F and lung neoplasm.